Aging women with polycystic ovary syndrome : menstrual cycles, metabolic health, and health-related quality of life
Ollila, Meri-Maija; Piltonen, Terhi T.; Tapanainen, Juha S.; Morin-Papunen, Laure (2020-02-28)
Meri-Maija Ollila, Terhi T. Piltonen, Juha S. Tapanainen, Laure Morin-Papunen, Aging women with polycystic ovary syndrome: menstrual cycles, metabolic health, and health-related quality of life, Current Opinion in Endocrine and Metabolic Research, Volume 12, 2020, Pages 14-19, ISSN 2451-9650, https://doi.org/10.1016/j.coemr.2020.02.010
© 2020 Elsevier B.V. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/.
https://creativecommons.org/licenses/by-nc-nd/4.0/
https://urn.fi/URN:NBN:fi-fe2020051838170
Tiivistelmä
Abstract
Women with polycystic ovary syndrome (PCOS) in their reproductive years present with metabolic dysfunction and thus increased likelihood of long-term health consequences and diminished well-being in later life. Owing to their larger ovarian reserve, however, they may experience menopause at later age and protection from metabolic and cardiovascular diseases. Moreover, previous studies have indicated that late reproductive-aged, normal-weight women with PCOS do not seem to have the expected high risk for type 2 diabetes (T2D), as previously thought. Health-related quality of life, nevertheless, is decreased in women with PCOS up until late fertile age, warranting attention and actions from the health care personnel. Given conflicting reports regarding the risk of cardiovascular diseases, future research with well characterized and adequately sized PCOS populations are needed, as well as studies aiming to improve their health-related quality of life.
Kokoelmat
- Avoin saatavuus [31924]